ANTARES PHARMA, INC. 3 SEC Filings

Filed On	Filing
29 Oct 2021	Form 3: Volkart Carmen B, Director No securities owned
28 Apr 2021	Form 3: Richardson Peter C, EVP, R&D Chief Medical Officer No securities owned
05 Mar 2019	Form 3: Smith Karen L., Director No securities owned
14 Dec 2018	Form 3: Greenleaf Peter, Director No securities owned
07 Aug 2018	Form 3: Tursi James Patrick, EVP, Chief Medical Officer No securities owned
02 Nov 2016	Form 3: Powell Fred M, Senior Vice President & CFO No securities owned
12 Sep 2016	Form 3: Muckenhirn Keith E, VP/Controller & Interim CFO Holds 50,000 shares of Common Stock
16 Jul 2015	Form 3: Graham Peter J, SVP General Counsel, Secretary No securities owned
13 May 2015	Form 3: Flynn James E, 10% owner and 5 others Holds 7,775,131 shares of Common stock
18 Nov 2014	Form 3: Fickenscher James E, Senior Vice President & CFO No securities owned
30 May 2014	Form 3: Stacey Jennifer Evans, SVP, General Counsel & Secty No securities owned
06 Aug 2013	Form 3: Roche Robert P Jr, Director Holds 5,000 shares of COMMON STOCK
24 May 2013	Form 3: Samson Marvin, Director No securities owned
08 Jun 2011	Form 3: Dave Kaushik J, Executive Vice President Holds 141,552 shares of Common Stock
14 Aug 2009	Form 3: Hobbs Eamonn P, Director No securities owned
18 Jan 2007	Form 3: Jacob Leonard S, Director No securities owned
13 Feb 2006	Form 3: Apple Robert F, Sr VP and CFO
23 Feb 2005	Form 3: Hattersley James E, Vice President-Business Develo
20 Aug 2004	Form 3: Wotton Paul K, Director Holds 20,000 shares of Antares Pharma Inc. common shares
26 Jul 2004	Form 3: Stover Jack E, President/COO Holds 30,000 shares of Antares Pharma, Inc. common shares

Comments